Followers | 144 |
Posts | 27707 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Wednesday, May 12, 2021 8:26:57 AM
https://finance.yahoo.com/news/evogene-financial-results-earnings-announcement-110000755.html
REHOVOT, Israel, May 12, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2021 on Wednesday, May 26th, 2021. Mr. Ido Dor, Chief Executive Officer of Evogene's subsidiary, Lavie Bio Ltd., will join the conference call to discuss Lavie Bio's recent activity.
On the day of the announcement, the Company's management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company's website at www.evogene.com.
A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial 1-888-326-9310 toll free from the United States, or +972-3-925-5901 internationally. The replay will be accessible through May 28th, and an archive of the webcast will be available on the webcast link for the following twelve months.
Recent EVGN News
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 09/19/2024 08:15:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/17/2024 11:00:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 08:01:22 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 09/04/2024 11:00:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/26/2024 01:30:23 PM
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 08/23/2024 12:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 12:50:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2024 11:00:28 AM
- Evogene Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/22/2024 11:00:00 AM
- Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule • PR Newswire (US) • 08/12/2024 11:11:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/12/2024 11:01:49 AM
- Evogene Schedules Second Quarter 2024 Financial Results Release • PR Newswire (US) • 08/12/2024 11:00:00 AM
- Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil • PR Newswire (US) • 07/31/2024 11:00:00 AM
- Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split • PR Newswire (US) • 07/23/2024 12:48:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/23/2024 11:00:10 AM
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants • PR Newswire (US) • 07/17/2024 12:00:00 PM
- Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat • PR Newswire (US) • 07/02/2024 11:00:00 AM
- Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country • PR Newswire (US) • 06/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 08:10:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:02:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 03:00:08 PM
- Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma • PR Newswire (US) • 05/23/2024 03:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 11:00:23 AM
- Evogene Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/23/2024 11:00:00 AM
- Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds • PR Newswire (US) • 05/21/2024 11:03:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM